Articles | Volume 6, issue 6
https://doi.org/10.5194/jbji-6-203-2021
© Author(s) 2021. This work is distributed under the Creative Commons Attribution 4.0 License.
Letter
| 
27 May 2021
Letter |
| 27 May 2021
| 27 May 2021
Reply to McNally's comment on “Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions – a single center experience” by Steinhausen et al. (2021)
Related authors
Cited articles
Bose, D., Kugan, R., Stubbs, D., and McNally, M.: Management of infected nonunion of the long bones by a multidisciplinary team, Bone Joint. J., 97, 814–817, https://doi.org/10.1302/0301-620X.97B6.33276, 2015.
Drampalos, E., Mohammad, H. R., and Pillai, A.: Aufmented debridement for implant related chronic osteomyelitis with an absorbable, gentamycin loaded calcium sulfate/hydroxyapatite biocomposite, J. Orthop., 13, 173–179, https://doi.org/10.1016/j.jor.2019.08.017, 2019.
Lam, A., Richardson, S. S., Buksbaum, J., Markowitz, J., Henry, M. W., Miller, A. O., Rozbruch, S. R., and Fragomen, A. T.: Chronic Osteomyelitis of the tibia and ankle treated with Limb Salvage Reconstruction, J. Bone Joint Infect., 4, 306–313, https://doi.org/10.7150/jbji.40337, 2019.
Lindfors, N., Geurts, J., Drago, L., Arts, J. J., Juutilainen, V., Hyvonen, P., Suda, A. J., Domenico, A., Artiaco, S., Alizadeh, C., Brychcy, A., Bialecki, J., and Romanò, C. L.: Antibacterial Bioactive Glass, S53P4, for Chronic Bone Infections – A Multinational Study, Adv. Exp. Med. Biol., 971, 81–92, 2017.
Malat, T. A., Glombitza, M., Dahmen, J., Hax, P.-M., and Steinhausen, E.: The Use of Bioactive Glass S53P4 as
Bone Graft Substitute in the Treatment of Chronic Osteomyelitis and Infected Non-Unions – a Retrospective Study of 50 Patients, Z. Orthop. Unfall., 156, 152–159, https://doi.org/10.1055/s-0043-124377, 2018.
